Ionescu Camelia, Ismail Gener, Constantinescu Ileana, Hortopan Monica, Iliescu Olguta, Rosu Mihaela, Voiculescu Mihai
Department of Internal Medicine - Nephrology, Fundeni Institute, Bucharest, Romania.
Rom J Gastroenterol. 2003 Dec;12(4):303-7.
Liver impairment in renal transplant recipients is not a common complication and is associated, in most cases, with viral infections (HBV, HCV, HVD, HGV) or drug hepatotoxicity (Cyclosporin, Azathioprine, statins). Cytomegalovirus (CMV) infection is common, with 50 to 80% of the adult population being seropositive for CMV antibodies. In immunocompetent individuals, primary infection is usually asymptomatic or associated with minor illness. CMV remains latent after primary infection. In immunocompromised patients, as in renal transplant recipients or transplant recipients of other solid organ or bone marrow, the virus can cause serious disease. This could be the result of newly acquired infection or reactivation of the latent virus. One of the organs involved in CMV disease is the liver. The subjects of this report are renal transplant recipients with liver impairment due to CMV induced acute hepatitis.
肾移植受者的肝功能损害并非常见并发症,在大多数情况下,与病毒感染(乙肝病毒、丙肝病毒、丁肝病毒、庚肝病毒)或药物肝毒性(环孢素、硫唑嘌呤、他汀类药物)有关。巨细胞病毒(CMV)感染很常见,50%至80%的成年人群CMV抗体呈血清阳性。在免疫功能正常的个体中,初次感染通常无症状或伴有轻微疾病。CMV在初次感染后潜伏。在免疫功能低下的患者中,如肾移植受者或其他实体器官或骨髓移植受者,该病毒可导致严重疾病。这可能是新获得感染或潜伏病毒重新激活的结果。CMV疾病累及的器官之一是肝脏。本报告的研究对象是因CMV诱导的急性肝炎而出现肝功能损害的肾移植受者。